Global Peptic Ulcer Market Growth Prospects, Future Industry Landscape 2033 | Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company

"The new report published by The Business Research Company, titled ""Peptic Ulcer Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the peptic ulcer market size has grown steadily in recent years. It will grow from $3.94 billion in 2023 to $4.1 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.69 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13221&type=smp

Obesity Fuels The Expansion Of The Peptic Ulcer Market
The growing prevalence of obesity is expected to propel the growth of the peptic ulcer market going forward. Obesity is a medical condition characterized by an excessive accumulation of body fat, typically resulting in an individual having a body mass index (BMI) of 30 or higher. Obesity can result from genetic, environmental, and lifestyle factors, such as a poor diet and a lack of physical activity. Obesity leads to the overproduction of stomach acid, weakens the stomach's protective mucosal lining, and contributes to developing peptic ulcers. Moreover, excess weight seems to promote inflammation in the gut, which can lead to the development of peptic ulcers. For instance, in March 2022, according to the World Obesity Atlas 2022 report, the estimated global number of people with obesity (Class I, II, and III) ≥30kg/m2 in 2020 was 764 million, expected to increase to 892 million by 2025. Therefore, the growing prevalence of obesity is driving the growth of the peptic ulcer market.

Advancements In Peptic Ulcer Treatment With Dartisla ODT's FDA Approval
Companies operating in the peptic ulcer market are developing innovative products and solutions and getting them approved by federal agencies to gain a competitive edge. Drug development is crucial in managing and treating peptic ulcers. It aids in symptom management, healing, preventing complications, and treating the underlying problem. For instance, in December 2021, the U.S. Food and Drug Administration approved Dartisla ODT. This new drug for peptic ulcer treatment aids functions by lessening symptoms. It is the first medication authorized as a supplement for treating peptic ulcer disease is Dartisla ODT. Dartisla ODT is known to have anticholinergic properties, as every tablet has been incorporated with 1.7 mg of glycopyrrolate.

The peptic ulcer market covered in this report is segmented -

1) By Disease Indication: Gastritis, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI), H2 Antagonists, Antibiotics, Other Drugs
3) By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Store, Retail Pharmacies, E-commerce

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13221&type=discount

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

Contents of the report:
1. Executive Summary
2. Peptic Ulcer Market Report Structure
3. Peptic Ulcer Market Trends And Strategies
4. Peptic Ulcer Market - Macro Economic Scenario
5. Peptic Ulcer Market Size And Growth
…..
27. Peptic Ulcer Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/peptic-ulcer-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.